InvestorsHub Logo


Followers 10
Posts 1339
Boards Moderated 0
Alias Born 03/26/2009


Re: None

Friday, 07/01/2022 3:06:38 PM

Friday, July 01, 2022 3:06:38 PM

Post# of 179
Interesting new Beneficial Owners recently. Taken an entry position today.
Looks like Covid-19 vaccines still hold prominent place in biotech research: "CureVac and GSK's second-generation vaccine candidate targeting two recent COVID-19 variants has been shown to be highly effective in preclinical studies on mice, CureVac said, as it seeks to catch up with rivals' development work."
Day Range:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CVAC News